A Real-World Analysis of Migraine: A Cross-Sectional Study of Disease Burden and Treatment Patterns
Author:
Affiliation:
1. Eli Lilly and Company; Indianapolis IN USA
2. Adelphi Real World, Adelphi Mill; Bollington UK
Funder
Eli Lilly and Company
Publisher
Wiley
Subject
Neurology (clinical),Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/head.13202/fullpdf
Reference30 articles.
1. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015;GBD 2015 Disease and Injury Incidence and Prevalence Collaborators;Lancet.,2016
2. The prevalence and burden of migraine and severe headache in the United States: Updated statistics from government health surveillance studies;Burch;Headache.,2015
3. The International Classification of Headache Disorders, 3rd edition (beta version);Headache Classification Committee of the International Headache Society (IHS);Cephalalgia.,2013
4. Migraine prevalence, disease burden, and the need for preventive therapy;Lipton;Neurology.,2007
5. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society;Silberstein;Neurology.,2012
Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Epidemiological, clinical characterization and treatment patterns of migraine patients in a Colombian cohort from 2018 to 2022.;2024-08-09
2. Patterns of migraine medication use in Norway: A nationwide registry-based observational study;Cephalalgia;2024-08
3. Profile of Sensory Integration Disorders in Migraine Patients—New Perspectives of Therapy;Journal of Clinical Medicine;2024-07-04
4. Construction and validation of a nomogram for predicting remission of migraine patients with patent foramen ovale after closure;International Journal of Cardiology;2024-07
5. The effectiveness and predictors influencing the outcome of onabotulinumtoxinA treatment in chronic migraine: understanding from diverse patient profiles in a single session;Frontiers in Neurology;2024-06-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3